CA
NZ
UK
AU
IND
US
Valion Bio, Inc. filed a Form 8-K on November 9, 2026, reporting that on November 6, 2026, it completed a closing under its Series B Non-Voting Convertible Preferred Stock purchase agreement with 3i, LP, raising $700,000 through the issuance of preferred shares and warrants.
Cabaletta Bio, Inc. filed a current report on November 9, 2026, disclosing new Phase 1/2 clinical data for rese-cel (resecabtagene autoleucel, formerly known as CABA-201) presented at the American College of Rheumatology Convergence 2026, covering outcomes across four autoimmune diseases.
Flag Ship Acquisition Corp. filed an 8-K on November 9, 2026, reporting the results of its annual general meeting of shareholders held on November 6, 2026, at which shareholders voted on director elections, auditor ratification, and an adjournment proposal.
Corebridge Financial, Inc. filed a Form 8-K on November 9, 2026, disclosing a Share Repurchase Agreement dated November 6, 2026, with Argon Holdco LLC to repurchase shares of its common stock for an aggregate purchase price of approximately $110 million.
Empresa Distribuidora y Comercializadora Norte S.A. (Edenor), listed on the NYSE as NYSE:EDN, filed a Form 6-K on November 9, 2026, reporting key financial and operating results for the nine-month period ended September 30, 2026.
Edesa Biotech, Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 8, 2026, the company entered into a Collaboration and License Agreement with Kyorin Pharmaceutical Co., Ltd. and terminated its at-the-market offering agreement with H.C. Wainwright & Co., LLC.
Korea Electric Power Corporation filed a Form 6-K on November 9, 2026, announcing that it plans to release preliminary unaudited consolidated earnings results for the third quarter of 2026 on November 12, 2026, accompanied by a conference call.
Empresa Distribuidora y Comercializadora Norte S.A. (Edenor) filed a Form 6-K with the U.S. Securities and Exchange Commission in November 2026, submitting its condensed interim consolidated financial statements as of September 30, 2026 and for the nine- and three-month periods then ended.
Claritev Corporation filed a Form 8-K on November 9, 2026, announcing that it had issued a press release reporting financial results for its third quarter ended September 30, 2026.
Ucommune International Ltd filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, reporting the results of an extraordinary general meeting of shareholders held that same day in Beijing, China.
Please wait processing your request...